1. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) (2007). The ocular surface 5 (2):93-107. doi:10.1016/s1542-0124(12)70082-4
2. Bron AJ, Tomlinson A, Foulks GN, Pepose JS, Baudouin C, Geerling G, Nichols KK, Lemp MA (2014) Rethinking dry eye disease: a perspective on clinical implications. The ocular surface 12 (2 Suppl):S1-31. doi:10.1016/j.jtos.2014.02.002
3. Eom Y, Na KS, Cho KJ, Hwang HS, Kim SW, Chung TY, Jun RM, Song JS, Kim HS (2019) Distribution and Characteristics of Meibomian Gland Dysfunction Subtypes: A Multicenter Study in South Korea. Korean journal of ophthalmology : KJO 33 (3):205-213. doi:10.3341/kjo.2018.0104
4. Knop E, Knop N, Millar T, Obata H, Sullivan DA (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Investigative ophthalmology & visual science 52 (4):1938-1978. doi:10.1167/iovs.10-6997c
5. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) (2007). The ocular surface 5 (2):75-92. doi:10.1016/s1542-0124(12)70081-2
6. Kook KY, Jin R, Li L, Yoon HJ, Yoon KC (2020) Tear Osmolarity and Matrix Metallopeptidase-9 in Dry Eye Associated with Sjögren's Syndrome. Korean journal of ophthalmology : KJO 34 (3):179-186. doi:10.3341/kjo.2019.0145
7. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X (2017) 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis & rheumatology (Hoboken, NJ) 69 (1):35-45. doi:10.1002/art.39859
8. García-Carrasco M, Fuentes-Alexandro S, Escárcega RO, Salgado G, Riebeling C, Cervera R (2006) Pathophysiology of Sjögren's syndrome. Archives of medical research 37 (8):921-932. doi:10.1016/j.arcmed.2006.08.002
9. Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y (2012) Sjögren's syndrome, the old and the new. Best practice & research Clinical rheumatology 26 (1):105-117. doi:10.1016/j.berh.2012.01.012
10. Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR (2004) Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scandinavian journal of rheumatology 33 (1):39-43. doi:10.1080/03009740310004676
11. Zhang NZ, Shi CS, Yao QP, Pan GX, Wang LL, Wen ZX, Li XC, Dong Y (1995) Prevalence of primary Sjögren's syndrome in China. The Journal of rheumatology 22 (4):659-661
12. Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S (2011) The complexity of Sjögren's syndrome: novel aspects on pathogenesis. Immunology letters 141 (1):1-9. doi:10.1016/j.imlet.2011.06.007
13. Mathers WD (1993) Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology 100 (3):347-351. doi:10.1016/s0161-6420(93)31643-x
14. Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K (1998) Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology 105 (8):1485-1488. doi:10.1016/s0161-6420(98)98033-2
15. Gurlevik U, Karakoyun A, Yasar E (2021) Does Sjogren's syndrome affect only the lacrimal gland in the eye? Time to replace the missing stones. Indian journal of ophthalmology 69 (1):53-57. doi:10.4103/ijo.IJO_2383_19
16. Goto E, Matsumoto Y, Kamoi M, Endo K, Ishida R, Dogru M, Kaido M, Kojima T, Tsubota K (2007) Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients. American journal of ophthalmology 144 (1):81-85. doi:10.1016/j.ajo.2007.03.055
17. Menzies KL, Srinivasan S, Prokopich CL, Jones L (2015) Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren's syndrome patients and nondry eye controls. Investigative ophthalmology & visual science 56 (2):836-841. doi:10.1167/iovs.14-13864
18. Zang S, Cui Y, Cui Y, Fei W (2018) Meibomian gland dropout in Sjögren's syndrome and non-Sjögren's dry eye patients. Eye (London, England) 32 (11):1681-1687. doi:10.1038/s41433-018-0149-5
19. Wang Y, Qin Q, Liu B, Fu Y, Lin L, Huang X, Jin X (2019) Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome. Frontiers in medicine 6:291. doi:10.3389/fmed.2019.00291
20. Zhao Y, Tan CL, Tong L (2015) Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness. BMC ophthalmology 15:53. doi:10.1186/s12886-015-0036-9
21. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T (2012) American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis care & research 64 (4):475-487. doi:10.1002/acr.21591
22. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X (2017) 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts. Annals of the rheumatic diseases 76 (1):9-16. doi:10.1136/annrheumdis-2016-210571
23. Toker E, Yavuz S, Direskeneli H (2004) Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome. The British journal of ophthalmology 88 (3):384-387. doi:10.1136/bjo.2003.028340
24. Srinivasan S, Menzies K, Sorbara L, Jones L (2012) Infrared imaging of meibomian gland structure using a novel keratograph. Optometry and vision science : official publication of the American Academy of Optometry 89 (5):788-794. doi:10.1097/OPX.0b013e318253de93
25. Garza-Leon M, Gonzalez-Dibildox A, Ramos-Betancourt N, Hernandez-Quintela E (2020) Comparison of meibomian gland loss area measurements between two computer programs and intra-inter-observer agreement. International ophthalmology 40 (5):1261-1267. doi:10.1007/s10792-020-01292-w
26. Blackie CA, Solomon JD, Scaffidi RC, Greiner JV, Lemp MA, Korb DR (2009) The relationship between dry eye symptoms and lipid layer thickness. Cornea 28 (7):789-794. doi:10.1097/ICO.0b013e318191b870
27. Kawashima M, Tsubota K (2013) Tear lipid layer deficiency associated with incomplete blinking: a case report. BMC ophthalmology 13:34. doi:10.1186/1471-2415-13-34
28. Kim JS, Lee H, Choi S, Kim EK, Seo KY, Kim TI (2018) Assessment of the Tear Film Lipid Layer Thickness after Cataract Surgery. Seminars in ophthalmology 33 (2):231-236. doi:10.1080/08820538.2016.1208764
29. Lee JH, Kim CH, Choe CM, Choi TH (2020) Correlation Analysis between Ocular Surface Parameters with Subjective Symptom Severity in Dry Eye Disease. Korean journal of ophthalmology : KJO 34 (3):203-209. doi:10.3341/kjo.2019.0133
30. Zhang J, Wu Z, Sun L, Liu XH (2020) Function and Morphology of the Meibomian Glands Using a LipiView Interferometer in Rotating Shift Medical Staff. Journal of ophthalmology 2020:3275143. doi:10.1155/2020/3275143
31. Su Y, Liang Q, Su G, Wang N, Baudouin C, Labbe A (2018) Spontaneous Eye Blink Patterns in Dry Eye: Clinical Correlations. Investigative ophthalmology & visual science 59 (12):5149-5156. doi:10.1167/iovs.18-24690
32. Eom Y, Na KS, Cho KJ, Hwang HS, Kim SW, Chung TY, Jun RM, Song JS, Kim HS, Korea Meibomian G, Ocular Surface Study G (2019) Distribution and Characteristics of Meibomian Gland Dysfunction Subtypes: A Multicenter Study in South Korea. Korean journal of ophthalmology : KJO 33 (3):205-213. doi:10.3341/kjo.2018.0104
33. Asiedu K, Kyei S, Mensah SN, Ocansey S, Abu LS, Kyere EA (2016) Ocular Surface Disease Index (OSDI) Versus the Standard Patient Evaluation of Eye Dryness (SPEED): A Study of a Nonclinical Sample. Cornea 35 (2):175-180. doi:10.1097/ico.0000000000000712
34. Asiedu K (2017) Rasch Analysis of the Standard Patient Evaluation of Eye Dryness Questionnaire. Eye & contact lens 43 (6):394-398. doi:10.1097/icl.0000000000000288
35. Wilson G, Ren H, Laurent J (1995) Corneal epithelial fluorescein staining. Journal of the American Optometric Association 66 (7):435-441
36. Greco G, Pistilli M, Asbell PA, Maguire MG (2020) Association of Severity of Dry Eye Disease with Work Productivity and Activity Impairment in the Dry Eye Assessment and Management Study. Ophthalmology. doi:10.1016/j.ophtha.2020.10.015
37. Møller-Hansen M, Larsen AC, Toft PB, Lynggaard CD, Schwartz C, Bruunsgaard H, Haack-Sørensen M, Ekblond A, Kastrup J, Heegaard S (2020) Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease. The ocular surface 19:43-52. doi:10.1016/j.jtos.2020.11.013
38. Kim M, Kim HS, Na KS (2017) Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome. Korean journal of ophthalmology : KJO 31 (1):25-31. doi:10.3341/kjo.2017.31.1.25
39. Kang YS, Lee HS, Li Y, Choi W, Yoon KC (2018) Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls. International ophthalmology 38 (3):1161-1167. doi:10.1007/s10792-017-0577-4
40. Akpek EK, Klimava A, Thorne JE, Martin D, Lekhanont K, Ostrovsky A (2009) Evaluation of patients with dry eye for presence of underlying Sjögren syndrome. Cornea 28 (5):493-497. doi:10.1097/ICO.0b013e31818d3846
41. Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, Uchino Y, Yokoi N, Zoukhri D, Sullivan DA (2017) TFOS DEWS II pathophysiology report. The ocular surface 15 (3):438-510. doi:10.1016/j.jtos.2017.05.011
42. Oh JY, Kim MK, Choi HJ, Ko JH, Kang EJ, Lee HJ, Wee WR, Lee JH (2011) Investigating the relationship between serum interleukin-17 levels and systemic immune-mediated disease in patients with dry eye syndrome. Korean journal of ophthalmology : KJO 25 (2):73-76. doi:10.3341/kjo.2011.25.2.73
43. Choi W, Ha JY, Li Y, Choi JH, Ji YS, Yoon KC (2019) Comparison of the meibomian gland dysfunction in patients with chronic ocular graft-versus-host disease and Sjögren's syndrome. International journal of ophthalmology 12 (3):393-400. doi:10.18240/ijo.2019.03.07
44. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ (1992) Sjögren's syndrome. A clinical, pathological, and serological study of sixty-two cases. 1965. Medicine 71 (6):386-401; discussion 401-383
45. Jester JV, Rife L, Nii D, Luttrull JK, Wilson L, Smith RE (1982) In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction. Investigative ophthalmology & visual science 22 (5):660-667
46. Pflugfelder SC, Huang AJ, Feuer W, Chuchovski PT, Pereira IC, Tseng SC (1990) Conjunctival cytologic features of primary Sjögren's syndrome. Ophthalmology 97 (8):985-991. doi:10.1016/s0161-6420(90)32478-8